A recent article published in PLOS Biology Journal examines the problems with the current practices and the indiscriminate uses of confidential business information (CBI) claims in biosafety assessments. […]
|
||||||
|
What has been achieved with the BCH is remarkable but the BCH is NOT sufficient to all the tasks required under the Cartegena Biosafety Protocol, nor does it contain the reliable and comprehensive information necessary for biosafety decision-making. […] This analysis addresses concerns about the Biosafety Clearing House established under the Cartegena Protocol on Biosafety as it currently exists in “pilot” form. […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||